359 related articles for article (PubMed ID: 19841288)
41. Aldosterone target organ protection by eplerenone.
Rudolph AE; Rocha R; McMahon EG
Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
[TBL] [Abstract][Full Text] [Related]
42. The influence of pharmacological mineralocorticoid and glucocorticoid receptor blockade on the cortisol response to psychological stress.
Deuter CE; Kaczmarczyk M; Hellmann-Regen J; Kuehl LK; Wingenfeld K; Otte C
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110905. PubMed ID: 38043634
[TBL] [Abstract][Full Text] [Related]
43. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats.
Buss SJ; Backs J; Kreusser MM; Hardt SE; Maser-Gluth C; Katus HA; Haass M
Endocrinology; 2006 May; 147(5):2526-34. PubMed ID: 16439456
[TBL] [Abstract][Full Text] [Related]
44. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
Rochetaing A; Chapon C; Marescaux L; Le Bouil A; Furber A; Kreher P
Can J Physiol Pharmacol; 2003 Sep; 81(9):864-72. PubMed ID: 14614522
[TBL] [Abstract][Full Text] [Related]
45. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
[TBL] [Abstract][Full Text] [Related]
46. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP
Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378
[TBL] [Abstract][Full Text] [Related]
47. Electrogenic Na+ transport in rat late distal colon by natural and synthetic glucocorticosteroids.
Grotjohann I; Schulzke JD; Fromm M
Am J Physiol; 1999 Feb; 276(2):G491-8. PubMed ID: 9950824
[TBL] [Abstract][Full Text] [Related]
48. Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system.
Mihailidou AS; Funder JW
Steroids; 2005; 70(5-7):347-51. PubMed ID: 15862816
[TBL] [Abstract][Full Text] [Related]
49. Aldosterone receptor antagonists.
Azizi M
Ann Endocrinol (Paris); 2021 Jun; 82(3-4):179-181. PubMed ID: 32473789
[TBL] [Abstract][Full Text] [Related]
50. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.
Young M; Head G; Funder J
Am J Physiol; 1995 Oct; 269(4 Pt 1):E657-62. PubMed ID: 7485478
[TBL] [Abstract][Full Text] [Related]
51. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
Navarro-Zaragoza J; Laorden ML; Milanés MV
Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
[TBL] [Abstract][Full Text] [Related]
52. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
53. Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats.
Rafiq K; Nakano D; Ihara G; Hitomi H; Fujisawa Y; Ohashi N; Kobori H; Nagai Y; Kiyomoto H; Kohno M; Nishiyama A
J Hypertens; 2011 Feb; 29(2):290-8. PubMed ID: 21243738
[TBL] [Abstract][Full Text] [Related]
54. Effects of corticosteroids on parameters related to Na+ transport by amphibian renal distal cells (A6) in culture.
Lyoussi B; Crabbé J
J Steroid Biochem Mol Biol; 1996 Nov; 59(3-4):323-31. PubMed ID: 9010324
[TBL] [Abstract][Full Text] [Related]
55. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone.
Mejía-Vilet JM; Ramírez V; Cruz C; Uribe N; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F78-86. PubMed ID: 17376767
[TBL] [Abstract][Full Text] [Related]
56. Protective effect of spironolactone on endothelial cell apoptosis.
Williams TA; Verhovez A; Milan A; Veglio F; Mulatero P
Endocrinology; 2006 May; 147(5):2496-505. PubMed ID: 16497808
[TBL] [Abstract][Full Text] [Related]
57. Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis.
Ren R; Oakley RH; Cruz-Topete D; Cidlowski JA
Endocrinology; 2012 Nov; 153(11):5346-60. PubMed ID: 22989630
[TBL] [Abstract][Full Text] [Related]
58. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
[TBL] [Abstract][Full Text] [Related]
59. Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction.
Yu HD; Xia S; Zha CQ; Deng SB; Du JL; She Q
J Cardiovasc Pharmacol; 2015 Jun; 65(6):587-92. PubMed ID: 26065643
[TBL] [Abstract][Full Text] [Related]
60. Effects of aldosterone and spironolactone on the isolated perfused rat heart.
Moreau D; Chardigny JM; Rochette L
Pharmacology; 1996 Jul; 53(1):28-36. PubMed ID: 8875599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
